Activated AKT together with deregulated PTEN and FOXO3a have been previously observed in ibrutinib-resistant CLL cells [29] as well as GAB1 upregulation leading to tonic AKT activity and increased homing capacity [30]. Here, AKT1 is linked to B-cell chronic lymphocytic leukemia.